Correlation Between Amylyx Pharmaceuticals and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Entero Therapeutics,, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Entero Therapeutics,.

Diversification Opportunities for Amylyx Pharmaceuticals and Entero Therapeutics,

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Amylyx and Entero is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Entero Therapeutics,

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 0.66 times more return on investment than Entero Therapeutics,. However, Amylyx Pharmaceuticals is 1.53 times less risky than Entero Therapeutics,. It trades about 0.01 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.04 per unit of risk. If you would invest  1,416  in Amylyx Pharmaceuticals on August 26, 2024 and sell it today you would lose (889.00) from holding Amylyx Pharmaceuticals or give up 62.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Entero Therapeutics, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Amylyx Pharmaceuticals and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Entero Therapeutics,

The main advantage of trading using opposite Amylyx Pharmaceuticals and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Amylyx Pharmaceuticals and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon